Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 8, 2013, Pages 641-649

  Korkmaz, Gulcan Guntas ^a   Konukoglu, Dildar ^b   Kurtulus, Eda Merve ^b   Irmak, Hulya ^b   Bolayirli, Murat ^b   Uzun, Hafize ^b  

^a Krklareli University   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Advanced protein oxidation products; Diabetic glucose tolerance; Impaired fasting glucose; Impaired glucose tolerance; Ischemia modified albumin; Prooxidant antioxidant balance; Total antioxidant capacity

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; GLUCOSE; ISCHEMIA MODIFIED ALBUMIN;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FERRIC REDUCING ANTIOXIDANT POWER; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROOXIDANT ANTIOXIDANT BALANCE; TISSUE INJURY;

ADVANCED OXIDATION PROTEIN PRODUCTS; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; COLORIMETRY; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; SERUM ALBUMIN;

EID: 84887578765     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.846477     Document Type: Article

References (37)

1. Penn L, White M, Lindstrm J, den Boer AT, Blaak E, Eriksson JG, Feskens E, Tlanne-Parikka P, KeinnenKiukaanniemi SM, Walker M, Mathers JC, Uusitupa M, Tuomilehto J. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 2013;8:e57143.
2. VazJA, PatnaikA. Diabetes mellitus: exploring the challenges in the drug development process. Perspect Clin Res 2012;3:109-12.
3. World Health Organization (WHO). Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of aWHO TDF consultation. Geneva: WHO, 2006.
4. Yamane T, Yokoyama A, Kitahara Y, Miyamoto 5, Haruta Y, Hattori N, Yamane K, Hara H, Kohno N. Cross-sectional and prospective study of the association between lung function and prediabetes. BMJ Open 2013;3:e002179.
5. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19: 708-23. (Pubitemid 35013848)
6. Marzouk M, Soliman AM, Omar TY. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats. Eur Rev Med Pharmacol Sci 2013;17:559-65.
7. Suresha BS,Vasantha KY, SatturAP, Srinivasan K. Beneficial influence of fungal metabolite nigerloxin on diabetes- induced oxidative stress in experimental rats. Can J Physiol Pharmacol 2013;91:149-56.
8. Korkmaz GG, Uzun H, Cakatay U, Aydin S. Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury. Clin Invest Med 2012;35:E370-7.
9. Cakatay U, Kayali R. The evaluation of altered redox status in plasma and mitochondria of acute and chronic diabetic rats. Clin Biochem 2006;39:907-12. (Pubitemid 44344685)
10. Serin 0, Konukoglu D, Firtina 5, Mavis 0. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Horm Metab Res 2007;39:207-11. (Pubitemid 46580620)
11. Gradinaru D, Borsa C, lonescu C, Margina D, Prada GI, Jansen E. Vitamin D status and oxidative stress markers in elderly with impaired fasting glucose and type 2 diabetes mellitus. Aging Clin Exp Res 2012;24:595-602
12. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5.
13. Zuwala-Jagiello J, Warwas M, Pazgan-Simon M. Ischemiamodified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim Pol 2012; 59:661-7.
14. Valle Gottlieb MG, da Cruz TB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010;95: 586-91.
15. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemiamodified albumin level in type 2 diabetes mellitus - preliminary report. Dis Markers 2008;24:31 1-7.
16. Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007;40:248-54. (Pubitemid 46108709)
17. Karacay 0, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalva 5, Akyol M, Kandemir 0, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract 2010; 89 :23 1-8.
18. Korkmaz GG, Altinoglu E, Civelek 5, SozerV, Erdenen F, Tabak 0, Uzun H.The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. Metabolism 2013;62:828-35.
19. Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, Sun X, Liu L. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007;112: 599-606. (Pubitemid 46849550)
20. Baschetti R. Evolutionary legacy: form of ingestion, not quantity, is the key factor in producing the effects of sugar on human health. Med Hypotheses 2004;63:933-8.
21. Gelisgen R, Genc H, Kayali R, Oncul M, Benian A, Guralp 0, Uludag 5, Cakatay U, Albayrak M, Uzun H. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res Clin Pract 2011;94: 404-9.
22. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1 996;239:70-6.
23. Alamdari DH, Ghayour-Mobarhan M,Tavallaie 5, Parizadeh MR, Moohebati M, Ghafoori F, Kazemi-Bajestani SM, Paletas K, Pegiou T, Koliakos G. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008;41: 375-80.
24. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt- albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2000;19: 311-5.
25. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia- modified albumin concentrations in patients with peripheral vascular disease and exercise- induced skeletal muscle ischemia. Clin Chem 2004;50: 1656-60. (Pubitemid 39121235)
26. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005;31:551-7. (Pubitemid 43001172)
27. Piwowar A, Knapik-Kordecka M,Warwas M. AOPP and its relations with selected markers of oxidative antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007;77:188-92. (Pubitemid 46670416)
28. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemiamodified albumin level in type 2 diabetes mellitus - preliminary report. Dis Markers 2008;24:31 1-7.
29. Piwowar A, Knapik-Kordecka M, Warwas M. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin Invest Med 2010;33:E109.
30. Kalousov M, Skrha J, Zima T. Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51: 597-604. (Pubitemid 36168668)
31. Witko-Sarsat V, Friedlander M, Capeillre-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Tnt 19 96;49 : 13 04-13.
32. Han K, Jia N, Yang L, Mm LQ. Correlation between ischemia-modified albumin and lipid levels in patients with acute cerebrovascular disease. Mol Med Rep 2012; 6:621-4.
33. Singh N, Bhardwaj P, Pandey RM, Saraya A. Oxidative stress and antioxidant capacity in patients with chronic pancreatitis with and without diabetes mellitus. Indian J Gastroenterol 2012;31:226-31.
34. Thiyagarajan R, Subramanian SK, Sampath N, Madanmohan Trakroo, Pal P, Bobby Z, Paneerselvam S, Das AK. Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study. PLoS One 2012;7: e41889.
35. Al-Shebly MM, Mansour MA. Evaluation of oxidative stress and antioxidant status in diabetic and hypertensive women during labor. Oxid Med Cell Longev 2012;2012: 329743.
36. Savu 0, Innescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R, Stoian I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Tnt Med Res 2012;40:709-16.
37. Savu 0, Bradescu OM, Serafinceanu C, Tosif L, Tirgoviste CI, Stoian I Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset. Redox Rep 2013 18 56-62.